Navigation Links
Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Date:9/16/2008

erving patients with cancer (Erbitux(R)), multiple sclerosis (Rebif(R)), infertility (Gonal-f(R)), endocrine and cardiometabolic disorders (Glucophage(R), Concor(R), Euthyrox(R), Saizen(R), Serostim(R)), as well as psoriasis (Raptiva(R)).

With an annual R&D expenditure of around EUR 1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in autoimmune and inflammatory diseases.

About Merck

Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.1 billion in 2007, a history that began in 1668, and a future shaped by 31,946 employees in 60 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit http://www.merckserono.net or http://www.merck.de


'/>"/>
SOURCE Merck Serono International S A
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
2. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
3. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
4. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
5. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
9. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
10. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
11. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... INDIANAPOLIS, Dec. 16 RealMed has ... Service in the 2009 Top 20 ... Services report. RealMed is a dynamic ... automated transactions processing between healthcare providers and ... independent research firm specializing in vendor performance ...
(Date:12/16/2009)... CareCentrix, Inc ., the nation,s leading provider ... that it has been awarded Health Utilization Accreditation ... organization that establishes quality standards for the health ... trained, qualified clinical personnel conduct and oversee the ... appeals process is in place, and that medical ...
(Date:12/16/2009)... MALVERN, Pa., Dec. 16 ... flexible financing solutions ... objectives and meet deadlines defined within the ... Reinvestment Act (ARRA). Featuring zero-percent ... enable organizations to defer up-front payments associated ...
Breaking Medicine Technology:RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3CareCentrix Receives URAC Health Utilization Management Accreditation 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4Nu Skin Enterprises to Announce Second Quarter 2009 Results 50675 1Why Swine Flu Differs From Seasonal Flu 50671 1Why Swine Flu Differs From Seasonal Flu 50671 2Why Swine Flu Differs From Seasonal Flu 50671 3CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... trials sponsored by its wholly owned subsidiary, ... IMPLANT for,the prevention of surgical site infections, ... is a fully biodegradable, leave-behind,surgical implant impregnated ...
... First Laboratory Developed Test in the U.S. for Detecting the ... Mosquito-Borne Infectious ... the,infectious disease diagnostics company of Quest Diagnostics (NYSE: DGX ... for,detecting the mosquito-borne chikungunya virus. Commercial availability of,the molecular polymerase ...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections 2Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections 3Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 2Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 3Focus Diagnostics Launches Laboratory Test for Chikungunya Virus 4
(Date:12/16/2009)... While many of the,pharma companies are struggling ... and inmarket drugs, MarketsandMarkets on the other ... players. These pharma,forecasting solutions are designed for ... phase,III. These have a substantial impact on ... strategy, manufacturing planning, sales force,promotion, and planning. ...
(Date:12/16/2009)... access to patient information could improve care, but ... 16 (HealthDay News) -- U.S. physicians support the ... exist about privacy problems, two new studies show. ... practice and specialist doctors in Massachusetts found that ... would improve patient quality of care, 70 percent ...
(Date:12/16/2009)... Reinertsen has run marathons, competed in triathalons and appeared on ... News) -- Sarah Reinertsen likes to think of herself as ... two-legged world is how the 34-year-old triathlete likes to describe ... find her speaking to packed school auditoriums or posing nude ... on the cover of the latest ESPN Body ...
(Date:12/16/2009)... trial bottle sample with purchase of 90-count bottle. , ... ... announces a special free offer for a “Free 21-Count ... Formula , with the purchase of a 90-count bottle. Distributed ... in FDA approved facilities and blends the 6 most important medicinal ...
(Date:12/16/2009)... /PRNewswire-FirstCall/ - TSO3 Inc. ("TSO3") (TSX: TOS) and ... been reached for 3M to be the exclusive ... The partnership with TSO3, an innovator in low ... settings through the use of ozone, will include ... 3M,s global sales channel. This agreement, combined with ...
Breaking Medicine News(10 mins):Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Pros and Cons of Electronic Medical Records Weighed 2Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4
... SnacksVENTURA, Calif., Jan. 30 thinkproducts ( www.thinkproducts.com ), ... bar producers, is pleased to announce the launch of ... bar category with 2 all natural portion control bars ... consumers underestimate the amount of food they eat and ...
... nearly two-thirds of surgeries , , FRIDAY, Jan. 30 (HealthDay ... are being done on an outpatient basis, according to a ... , From 1996 to 2006, the number of outpatient surgery ... says. In addition, outpatient surgery accounted for nearly two-thirds of ...
... whether vaginal birth would be safe, study says , , FRIDAY, ... uterine scar from a cesarean delivery can help physicians predict ... and may safely try to have a vaginal delivery, according ... the scar is, the stronger the scar is, and the ...
... the UCLA School of Public Health have found the ... that are widely used in everyday items such as ... products may be associated with infertility in women. ... Reproduction , Europe,s leading reproductive medicine journal, the study ...
... The California Science Center,s Science Matters speakers ... "Prescription Drugs: Good Medicine - Bad Behavior" on Saturday, February ... panelists will provide an overview of the science behind addiction ... the rapid rise of this addiction, questioning whether efforts to ...
... Investors Specify Concerns and Propose Remedies to Enzon CEO ... YORK, Jan. 30 On January 28, 2009, Knott ... shares of outstanding common stock of Enzon Pharmaceuticals, sent ... addressed to Enzon CEO Jeffrey Buchalter as well as ...
Other Medicine News:Health News:thinkproducts Celebrates the Launch of thinkThin bites 2Health News:Outpatient Procedures on Rise, CDC Says 2Health News:Using C-Section Scars to Predict Future Deliveries 2Health News:Using C-Section Scars to Predict Future Deliveries 3Health News:Household chemicals may be linked to infertility 2Health News:Household chemicals may be linked to infertility 3Health News:'Prescription Drugs: Good Medicine - Bad Behavior;' Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center 2Health News:'Prescription Drugs: Good Medicine - Bad Behavior;' Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center 3Health News:Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter 2Health News:Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter 3
... Slip on, warm with a ... to fit. Splint hardens as ... and reposition. Unique fiberglass knit ... polymer Straps included. Tape, 1" ...
... Blue Line ThumStay offers thumb and wrist ... soft, breathable foam. Lightweight stays provide firm ... can easily be contoured for proper positioning ... deQuervain's tenosynovitis, tendinitis, CMC joint arthritis, and ...
... contour at the palmar crease to allow for ... choice to treat mild to moderate wrist sprains ... following cast removal. The lightweight laminated foam ... provides support and compression to the wrist to ...
... is molded from rigid plastic in a distinctive ... wearing comfort. The uniquely sculpted distal trim ... preserves maximum function of the hand. This ... strains and sprains of the MCP joint, basal ...
Medicine Products: